We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy

News   Jul 03, 2017 | Original story from St. Jude Children’s Research Hospital

 
Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy

(from left) Corresponding author Benjamin Youngblood, Ph.D., is with first author Hazem Ghoneim, Ph.D. Credit: St. Jude Children’s Research Hospital

 
 
 

RELATED ARTICLES

Membrane Proteins Ejected Directly from Cell Membrane to Mass Spec

News

A new approach to analyzing cell membrane proteins in situ could revolutionize the way in which we study diseases, such as cancer, metabolic and heart diseases.

READ MORE

Drug Candidate Could Recover Vocal Abilities Lost to ADNP Syndrome

News

A new Tel Aviv University study finds that the drug candidate CP201, also known as NAP, may improve vocal communication abilities that are underdeveloped in Activity-dependent neuroprotective protein (ADNP) patients.

READ MORE

New Inflammation Inhibitor Discovered

News

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE